Skip to main content
Premium Trial:

Request an Annual Quote

Francis Collins' "Scientific and Scriptural Truth"

With funding from the John Templeton Foundation, Francis Collins has launched a new foundation called BioLogos, which "promotes the search for truth in both the natural and spiritual realms, and seeks to harmonize these different perspectives." Collins hopes to show Christians, particularly evangelicals, that faith and science are compatible. For example, he tells Time magazine that Christians should consider the book of Genesis "not as a book about science but about the nature of God and the nature of humans. Evolution gives us the 'how,' but we need the Bible to understand the 'why' of our creation." The website answers questions ranging from "Can scientific and scriptural truth be reconciled?" to "Was there death before the Fall?"

Jonathan Eisen says he looked at the BioLogos website with "some horror." "Science (and medicine) should be about, well, science. And religion can be about whatever it wants to be. … But merging the two together into one hybrid such as Christian Science and Creation Science? Not for me," he writes. Larry Moran and PZ Myers also weigh in.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.